Fiasp, a rapid-acting insulin for people with type 2 or type 2 diabetes, was recently approved for use in insulin pumps and provides another option for people to help improve their post-meal blood sugars.
read more →
Inhaled insulin Afrezza is a great option for a lot of people living with type 1 and type 2 diabetes because it doesn’t involve shots and has a rapid on-rapid off effect. The makers of Afrezza just announced a direct purchase program to help people get it for as little as $4 a day.
read more →
With several new fast-acting insulins on the market, is it still necessary to pre-bolus before meals? How fast-acting are they really? Endocrinologist and type 1 Dr. Jeremy Pettus compares, contrasts, and gives his vote.
read more →
